Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2008 1
2009 1
2011 1
2012 1
2013 5
2014 2
2015 6
2016 5
2017 5
2018 10
2019 28
2020 59
2021 37
2022 5
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 32487555

154 results
Results by year
Filters applied: . Clear all
Page 1
How to: prophylactic interventions for prevention of Clostridioides difficile infection.
Reigadas E, van Prehn J, Falcone M, Fitzpatrick F, Vehreschild MJGT, Kuijper EJ, Bouza E; European Society of Clinical Microbiology and Infectious Diseases Study Group on Clostridioides difficile (ESGCD) and Study Group for Host and Microbiota interaction (ESGHAMI). Reigadas E, et al. Clin Microbiol Infect. 2021 Dec;27(12):1777-1783. doi: 10.1016/j.cmi.2021.06.037. Epub 2021 Jul 8. Clin Microbiol Infect. 2021. PMID: 34245901 Review.
SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection.
Feuerstadt P, Louie TJ, Lashner B, Wang EEL, Diao L, Bryant JA, Sims M, Kraft CS, Cohen SH, Berenson CS, Korman LY, Ford CB, Litcofsky KD, Lombardo MJ, Wortman JR, Wu H, Auniņš JG, McChalicher CWJ, Winkler JA, McGovern BH, Trucksis M, Henn MR, von Moltke L. Feuerstadt P, et al. N Engl J Med. 2022 Jan 20;386(3):220-229. doi: 10.1056/NEJMoa2106516. N Engl J Med. 2022. PMID: 35045228 Clinical Trial.
154 results